LTR Pharma Limited
LTPLF
$0.27
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.50M | -4.54M | -4.57M | -3.40M | -2.24M |
| Total Depreciation and Amortization | 600.00 | 300.00 | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 655.90K | 760.70K | 865.90K | 616.20K | 368.80K |
| Change in Net Operating Assets | 358.20K | 358.20K | 358.20K | 137.70K | -83.40K |
| Cash from Operations | -3.48M | -3.42M | -3.34M | -2.65M | -1.96M |
| Capital Expenditure | -7.10K | -4.30K | -1.40K | -1.40K | -1.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -7.10K | -4.30K | -1.40K | -1.40K | -1.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 35.50M | 21.25M | 7.00M | 7.72M | 8.45M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.13M | -1.32M | -504.00K | -538.50K | -573.00K |
| Cash from Financing | 22.05M | 13.30M | 4.24M | 4.70M | 5.18M |
| Foreign Exchange rate Adjustments | -18.40K | -18.40K | -18.40K | -17.10K | -16.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.54M | 9.85M | 882.60K | 2.04M | 3.20M |